Kamphuis E, Krämer B, Schildger H, Duchow K
Division of Veterinary Medicine, Paul-Ehrlich Institut, Langen, Germany.
Dev Biol (Basel). 2012;134:23-7.
Batch potency testing of rabies vaccines could be done by challenge, measurement of serum response or antigen quantification. Here, we show the development of a serological test that was successfully validated for use in batch release. The serological test is based on serum neutralization (SNT). The correlation to the NIH challenge was demonstrated by batches passing respectively failing equivalently in the NIH and SNT. The SNT provides information on immunogenicity and exhibits several advantages to the NIH: 1) SNT uses many fewer animals for batch release. 2) SNT allows quantitative information on the individual serum response, in contrast to the "dead"/"alive" interpretation of the NIH. 3) SNT is quicker than the NIH and needs fewer working hours. 4) SNT avoids the highly disturbing intra-cerebral injection and suffering from rabies for mice and spares the staff the emotional stress of massively harming animals.
狂犬病疫苗的批次效力检测可通过攻毒、血清反应测定或抗原定量来进行。在此,我们展示了一种血清学检测方法的开发,该方法已成功验证可用于批签发。该血清学检测基于血清中和试验(SNT)。通过在国立卫生研究院(NIH)攻毒试验和SNT中分别等效通过或失败的批次,证明了其与NIH攻毒试验的相关性。SNT提供了关于免疫原性的信息,并且相对于NIH攻毒试验具有几个优点:1)SNT在批签发时使用的动物数量少得多。2)与NIH的“死”/“活”判定不同,SNT能够提供关于个体血清反应的定量信息。3)SNT比NIH攻毒试验更快,所需工作时间更少。4)SNT避免了对小鼠进行极具干扰性的脑内注射以及狂犬病感染,使工作人员免受大量伤害动物所带来的情感压力。